UN Monkeypox Article Megathread

  • Want to keep track of this thread?
    Accounts can bookmark posts, watch threads for updates, and jump back to where you stopped reading.
    Create account
Article (Archive)

Four more people have been diagnosed with monkeypox in the UK, bringing the total number of cases in the latest outbreak to seven.

All four new patients are gay or bisexual men who were infected in London and had no travel links to Africa, health chiefs have confirmed after MailOnline broke the news earlier today.

Two are known to each other but have no connection to any of the previous cases, in a sign the virus is spreading in the community for the first time.

Nurses and doctors are being advised to stay 'alert' to patients who present with a new rash.

Monkeypox is often mistaken for more common rash illnesses like chickenpox, measles, scabies and syphilis, which makes it difficult to diagnose early.

Dr Susan Hopkins, chief medical adviser at the UK Health Security Agency (UKHSA), said: 'This is rare and unusual.

'UKHSA is rapidly investigating the source of these infections because the evidence suggests that there may be transmission of the monkeypox virus in the community, spread by close contact.

'We are particularly urging men who are gay and bisexual to be aware of any unusual rashes or lesions and to contact a sexual health service without delay.'

All seven UK cases have tested positive for the West African strain of the virus, which is believed to be milder than other versions.
Untitled.jpg
Six of the seven cases were diagnosed in London while one is being treated at a specialist unit in Newcastle
Untitled.jpg
Monkeypox is a rare viral infection which causes unusual rashes or lesions (shown in a handout provided by the Centers for Disease Control and Prevention (CDC) in the US

Exactly how the new patients acquired the infection 'remains under urgent investigation', the UKHSA said.

The rare viral infection which kills up to one in ten of those infected but does not spread easily between people. It is transmitted via respiratory droplets during prolonged face-to-face contact or bodily fluids.

MailOnline has learned that at least one sexual health clinic in West London had started implementing tougher infection control measures this morning, including a one-metre social distancing rule in waiting rooms.

A source told MailOnline that some health teams were breaking ranks from national guidance and 'perhaps putting in measures locally'.

The UKHSA announced on May 7 that a person who had recently travelled to Nigeria had contracted the infection.

It was believed they contracted the illness in Nigeria, where monkeypox is endemic, before travelling to the UK.

Two more cases were announced on Saturday, in two individuals who lived in the same household but were not linked to the initial case.
Untitled.jpg
Nurses and doctors are being advised to stay 'alert' to patients who present with a new rash or scabby lesions (like above)
The rare tropical disease, which causes flu-like symptoms and blisters on the skin, is caused by a virus spread by monkeys, rats, squirrels and other small mammals.

A World Health Organization report last year suggested the natural R rate of the virus – the number of people each patient would infect if they lived normally while sick – is two.

But the real rate is likely much lower because 'distinctive symptoms greatly aid in its early detection and containment,' the team said, meaning it's easy to spot cases and isolate them.

Up to 10 per cent of people who become ill with monkeypox will die and most deaths from the virus occur in younger age groups, according to the WHO.

The first case of monkeypox in a human was recorded in 1970 in the Democratic Republic of the Congo and has since been detected in a number of central and wester African countries.

Most cases are reported in the DRC and Nigeria.

In 2003, the disease was detected in the US when an outbreak occurred following the importation of rodents from Africa.

The first cases were detected in the UK in 2018, when three people contracted the virus after a man travelled back from Nigeria including an NHS nurse who had been caring for a patient and blamed her PPE.

The incident meant more than 50 people were warned they had been exposed to the potentially deadly virus however no other cases were recorded from that outbreak.

A further case was detected in London in December 2019 and another two cases were detected in North Wales in 2021. All cases were thought to have been caught by travellers who had been to Nigeria.

A WHO report in 2020 explained that human-to-human transmission of the virus is rare and that the longest chain of cases appears to only have been six people before it ended.

The report said: 'The epidemic risk for humans is considered to be small.'
 
Last edited by a moderator:
https://promedmail.org/promed-post/?id=8704627 archive: https://archive.ph/MDKF5

ProMED-mail said:
MONKEYPOX UPDATE (37)
*********************
A ProMED-mail post
ProMED-mail is a program of the
International Society for Infectious Diseases

Date: Sat 23 Jul 2022
Source: WHO director-general's statement [edited]


Good morning, good afternoon and good evening.

A month ago, I convened the Emergency Committee under the International Health Regulations to assess whether the multi-country monkeypox outbreak represented a public health emergency of international concern. At that meeting, while differing views were expressed, the committee resolved by consensus that the outbreak did not represent a public health emergency of international concern. At the time, 3040 cases of monkeypox had been reported to WHO, from 47 countries.

Since then, the outbreak has continued to grow, and there are now more than 16 000 reported cases from 75 countries and territories, and 5 deaths. In light of the evolving outbreak, I reconvened the committee on Thursday of this week [21 Jul 2022] to review the latest data and advise me accordingly. I thank the committee for its careful consideration of the evidence, and issues.

On this occasion, the committee was unable to reach a consensus on whether the outbreak represents a public health emergency of international concern. The reasons the committee members gave for and against are laid out in the report we are publishing today [23 Jul 2022].

Under the International Health Regulations, I am required to consider 5 elements in deciding whether an outbreak constitutes a public health emergency of international concern.

1st, the information provided by countries -- which in this case shows that this virus has spread rapidly to many countries that have not seen it before;
2nd, the 3 criteria for declaring a public health emergency of international concern, which have been met;
3rd, the advice of the Emergency Committee, which has not reached consensus;
4th, scientific principles, evidence and other relevant information -- which are currently insufficient and leave us with many unknowns;
and 5th, the risk to human health, international spread, and the potential for interference with international traffic.

WHO's assessment is that the risk of monkeypox is moderate globally and in all regions, except in the European region where we assess the risk as high. There is also a clear risk of further international spread, although the risk of interference with international traffic remains low for the moment. So in short, we have an outbreak that has spread around the world rapidly, through new modes of transmission, about which we understand too little, and which meets the criteria in the International Health Regulations.

For all of these reasons, I have decided that the global monkeypox outbreak represents a public health emergency of international concern. Accordingly, I have made a set of recommendations for 4 groups of countries:

1st, those that have not yet reported a case of monkeypox, or have not reported a case for more than 21 days;
2nd, those with recently imported cases of monkeypox and that are experiencing human-to-human transmission.

This includes recommendations to implement a coordinated response to stop transmission and protect vulnerable groups;
to engage and protect affected communities;
to intensify surveillance and public health measures;
to strengthen clinical management and infection prevention and control in hospitals and clinics;
to accelerate research into the use of vaccines, therapeutics and other tools;
and recommendations on international travel.

The 3rd group of countries is those with transmission of monkeypox between animals and humans;
and the 4th is countries with manufacturing capacity for diagnostics, vaccines and therapeutics.

My full recommendations are laid out in my statement.

I thank the Emergency Committee for its deliberations and advice. I know this has not been an easy or straightforward process, and that there are divergent views among the members. The International Health Regulations remains a vital tool for responding to the international spread of disease. But this process demonstrates once again that this vital tool needs to be sharpened to make it more effective.

So I'm pleased that alongside the process of negotiating a new international accord on pandemic preparedness and response, WHO's member states are also considering targeted amendments to the International Health Regulations, including ways to improve the process for declaring a public health emergency of international concern.

Although I am declaring a public health emergency of international concern, for the moment this is an outbreak that is concentrated among men who have sex with men, especially those with multiple sexual partners. That means that this is an outbreak that can be stopped with the right strategies in the right groups. It's therefore essential that all countries work closely with communities of men who have sex with men, to design and deliver effective information and services, and to adopt measures that protect the health, human rights and dignity of affected communities.

Stigma and discrimination can be as dangerous as any virus. In addition to our recommendations to countries, I am also calling on civil society organizations, including those with experience in working with people living with HIV, to work with us on fighting stigma and discrimination. But with the tools we have right now, we can stop transmission and bring this outbreak under control.

I thank you.

--
communicated by:
ProMED

[The WHO director general's declaration of the monkeypox outbreak as a public health emergency of international concern will focus world attention on the current situation. One hopes that this declaration will result in increased funding for surveillance and contact tracing and for increased vaccine production and distribution that will reach this disease's most vulnerable cohort. - Mod.TY]
 
Apparently there is some neurological component to monkeypox disease, though base rates were not accounted for in this article.
******
[6] Possible neurological problems
Date: Fri 9 Sep 2022 05:47 EDT
Source: The Conversation [edited]


Monkeypox's effect on the skin -- the disfiguring rashes -- and the flu-like symptoms have been well described, but few have investigated the neurological and psychiatric problems the virus might cause.

There are historic reports of neurological complications in people infected with the related smallpox virus and in people vaccinated against smallpox, which contains the related vaccinia virus. So my colleagues and I wanted to know whether monkeypox causes similar problems.

We looked at all the evidence from before the current monkeypox pandemic of neurological or psychiatric problems in people with a monkeypox infection. The results are published in the journal eClinicalMedicine (https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(22)00374-1/fulltext).

A small but noticeable proportion of people (2%-3%) with monkeypox became very unwell and developed serious neurological problems, including seizure and encephalitis (inflammation of the brain that can cause long-term disability). We also found that confusion occurred in a similar number of people. It's important to note, though, that these figures are based on a few studies with few participants.

Besides the severe and rare brain problems, we found evidence of a broader group of people with monkeypox who had more common neurological symptoms including headache, muscle ache and fatigue. From looking at the studies, it was unclear how severe these symptoms were and how long they lasted. It was also unclear how many people with monkeypox had psychiatric problems -- such as anxiety and depression -- as few studies looked into it. Of those that did, low mood was frequently reported.

We don't know what factors are driving these neuropsychiatric problems in people with monkeypox. We would want to know whether the strain of monkeypox virus and the severity of infection affects these problems. However, we were unable to look into this properly because it was not consistently reported in studies.

Although we found that people with monkeypox infection can have neuropsychiatric symptoms, the studies in our paper cannot say with any certainty that it's the virus causing these problems. Future research exploring this will need to follow up people with no neuropsychiatric conditions before becoming infected with monkeypox.

If it is the virus that is causing these problems, the biological processes underlying it are unclear and could involve the virus directly entering the nervous system, a reaction by the immune system or something else entirely. It's also possible that the stigma people experience from monkeypox infection and the effect of disfiguring skin rashes could contribute to psychological distress such as low mood.

Our research focused on the evidence before the current monkeypox pandemic. Most of the data were from west Africa and in people hospitalised with an infection, whereas the current pandemic has predominantly affected North America and western Europe. It is unclear to what degree the symptoms of previous outbreaks will mirror what we are seeing now.

Important research has come out since we finished our paper. A study in the New England Journal of Medicine included over 500 people with monkeypox from 16 countries in the current outbreak. Although no cases of encephalitis or seizure were reported, headache and fatigue were found in more than a quarter of people infected with monkeypox and low mood in up to one in 10 people.

However, there have been 2 recently reported cases of monkeypox-confirmed encephalitis in Spain. Further surveillance is needed to determine the true extent of more serious problems like encephalitis and seizure.

The monkeypox outbreak remains a global concern, and ongoing public health measures, including improving access to vaccination, are needed.

Although monkeypox mainly causes flu-like symptoms and skin problems, our latest study -- and subsequent studies -- shows that neuropsychiatric symptoms are not uncommon. We are not expecting a tide of serious brain problems, but complications such as encephalitis and seizure may occur in a small proportion of people. We need more research to find out if these symptoms persist over time and whether they're caused by monkeypox.

[Byline: James Brunton Badenoch]

--
Communicated by:
ProMED
 
View attachment 3537580
THE GAYS HAVE DONE IT AGAIN. HIV 2 HERE WE COME.

Also

>WHO reinforcing gay stereotype of having multiple lovers

Kek lmao
It would have been much better if they'd come out and said 'don't fuck multiple guys at the same time'. Talking about 'multiple partners' falsely implies that degenerate heterosexuals can get monkeypox (that only applies to the animals catching monkeypox, the kids were probably getting turned gay anyway).
 
More to add to my faggot L's collection to show those who say that LGB isn't as bad as the T.
I'm going to voice my doubt that women are spreading the noggypox, much less to children. I'm exempting nigresses, of course. I'm quite certain that the "L" and TIFs aren't at issue here and aren't a threat.
 
WHO renames monkeypox to MPOX and monkeypox virus to MPOXv. https://www.politico.com/news/2022/11/22/who-monkeypox-mpox-rename-00070614 https://archive.ph/opPnp
The World Health Organization is planning to rename monkeypox, designating it as “MPOX” in an effort to destigmatize the virus that gained a foothold in the U.S. earlier this year, three people with knowledge of the matter told POLITICO.
The decision, which could be announced as early as Wednesday, follows an initial agreement the WHO made over the summer to consider suggestions for monkeypox’s new name.
It also comes in response to growing pressure from senior Biden officials, who privately urged WHO leaders to change the name and suggested the U.S. would act unilaterally if the international body did not move quickly enough.
The WHO traditionally acts as a global coordinator on public health issues, including declaring international health emergencies and recommending names for diseases that are then adopted by individual countries.
But the Biden administration for months worried that the virus’ name was deepening stigma — especially among people of color — and that the slow movement toward a new designation was hampering the vaccination campaign it started over the summer, the people with knowledge of the matter said.
The WHO did not immediately respond to a request for comment. The White House declined to comment.
Public health experts and LGBT activists had similarly called for abandoning the virus’ name, which it received upon its discovery in 1958, since it began spreading widely this past spring. They argued that calling it the monkeypox is imprecise, plays into racist stereotypes about Africa and is detrimental to the global response.
“In the context of the current global outbreak, continued reference to, and nomenclature of this virus being African is not only inaccurate but is also discriminatory and stigmatizing,” a group of scientists wrote in a joint statement published in June.
The virus soon to be known as MPOX began spreading rapidly within the U.S. in May, catching health officials off-guard and spurring a nationwide push to bring the outbreak under control. The White House in August took over management of the response, appointing a pair monkeypox response coordinators.
The U.S. has recorded nearly 30,000 infections during the outbreak, according to Centers for Disease Control and Prevention data, with the virus overwhelmingly affecting the community of men who have sex with men.
But aided by the government’s vaccination push, the initial crisis appears to have abated, with new cases falling precipitously from a high of more than 400 per day over the summer to daily national caseloads in the teens over the last week.
 
WHO renames monkeypox to MPOX and monkeypox virus to MPOXv. https://www.politico.com/news/2022/11/22/who-monkeypox-mpox-rename-00070614 https://archive.ph/opPnp
The World Health Organization is planning to rename monkeypox, designating it as “MPOX” in an effort to destigmatize the virus that gained a foothold in the U.S. earlier this year, three people with knowledge of the matter told POLITICO.
The decision, which could be announced as early as Wednesday, follows an initial agreement the WHO made over the summer to consider suggestions for monkeypox’s new name.
It also comes in response to growing pressure from senior Biden officials, who privately urged WHO leaders to change the name and suggested the U.S. would act unilaterally if the international body did not move quickly enough.
The WHO traditionally acts as a global coordinator on public health issues, including declaring international health emergencies and recommending names for diseases that are then adopted by individual countries.
But the Biden administration for months worried that the virus’ name was deepening stigma — especially among people of color — and that the slow movement toward a new designation was hampering the vaccination campaign it started over the summer, the people with knowledge of the matter said.
The WHO did not immediately respond to a request for comment. The White House declined to comment.
Public health experts and LGBT activists had similarly called for abandoning the virus’ name, which it received upon its discovery in 1958, since it began spreading widely this past spring. They argued that calling it the monkeypox is imprecise, plays into racist stereotypes about Africa and is detrimental to the global response.
“In the context of the current global outbreak, continued reference to, and nomenclature of this virus being African is not only inaccurate but is also discriminatory and stigmatizing,” a group of scientists wrote in a joint statement published in June.
The virus soon to be known as MPOX began spreading rapidly within the U.S. in May, catching health officials off-guard and spurring a nationwide push to bring the outbreak under control. The White House in August took over management of the response, appointing a pair monkeypox response coordinators.
The U.S. has recorded nearly 30,000 infections during the outbreak, according to Centers for Disease Control and Prevention data, with the virus overwhelmingly affecting the community of men who have sex with men.
But aided by the government’s vaccination push, the initial crisis appears to have abated, with new cases falling precipitously from a high of more than 400 per day over the summer to daily national caseloads in the teens over the last week.
Why would you want to destigmatize an STD?
 
It sure seems like this disease in the news has been brought around back and shot. I wonder why? Whatever could be the reason? Eh, I suppose no one will ever know.
WHO renames monkeypox to MPOX and monkeypox virus to MPOXv. https://www.politico.com/news/2022/11/22/who-monkeypox-mpox-rename-00070614 https://archive.ph/opPnp
The World Health Organization is planning to rename monkeypox, designating it as “MPOX” in an effort to destigmatize the virus that gained a foothold in the U.S. earlier this year, three people with knowledge of the matter told POLITICO.
The decision, which could be announced as early as Wednesday, follows an initial agreement the WHO made over the summer to consider suggestions for monkeypox’s new name.
It also comes in response to growing pressure from senior Biden officials, who privately urged WHO leaders to change the name and suggested the U.S. would act unilaterally if the international body did not move quickly enough.
The WHO traditionally acts as a global coordinator on public health issues, including declaring international health emergencies and recommending names for diseases that are then adopted by individual countries.
But the Biden administration for months worried that the virus’ name was deepening stigma — especially among people of color — and that the slow movement toward a new designation was hampering the vaccination campaign it started over the summer, the people with knowledge of the matter said.
The WHO did not immediately respond to a request for comment. The White House declined to comment.
Public health experts and LGBT activists had similarly called for abandoning the virus’ name, which it received upon its discovery in 1958, since it began spreading widely this past spring. They argued that calling it the monkeypox is imprecise, plays into racist stereotypes about Africa and is detrimental to the global response.
“In the context of the current global outbreak, continued reference to, and nomenclature of this virus being African is not only inaccurate but is also discriminatory and stigmatizing,” a group of scientists wrote in a joint statement published in June.
The virus soon to be known as MPOX began spreading rapidly within the U.S. in May, catching health officials off-guard and spurring a nationwide push to bring the outbreak under control. The White House in August took over management of the response, appointing a pair monkeypox response coordinators.
The U.S. has recorded nearly 30,000 infections during the outbreak, according to Centers for Disease Control and Prevention data, with the virus overwhelmingly affecting the community of men who have sex with men.
But aided by the government’s vaccination push, the initial crisis appears to have abated, with new cases falling precipitously from a high of more than 400 per day over the summer to daily national caseloads in the teens over the last week.
No one will ever know!
 
We are SO back

Pride month is here and mpox remains a threat, but vaccines are more readily available (Lite) (archive)

By Jen Christensen, CNN
Thu June 6, 2024

As the LGBTQ+ community gears up for Pride celebrations this month, the US Centers for Disease Control and Prevention hopes people will get more than just their rainbow gear and sunscreen ready. The agency is urging more people – particularly some gay and bisexual men – to get the mpox vaccine.

The US Department of Health and Human Services plans to be at dozens of Pride and community events across the country to remind people that mpox is still a problem in the United States, but with vaccination, it doesn’t have to be.

Anyone can get sick with mpox, the painful and sometimes deadly disease formerly known as monkeypox. But in the global outbreak that started in 2022, certain members of the LGBTQ+ community are considered especially vulnerable. According to recent case reports, 90% of those who got mpox in the US during this outbreak who reported their sexual orientation were men who identified as gay or bisexual. And nearly all of those who got sick were unvaccinated.

“For folks who have not yet gotten two doses of the Jynneos vaccine, it’s really important for protecting them from this disease,” said Alex Tuttle, an epidemiologist with the Poxvirus and Rabies Branch of the CDC. “About a quarter of the population that we believe is at risk is currently vaccinated, so we really want to push that up, especially as we’re going into these summer months where risk might be heightened a little bit.”

Mpox is a viral disease that can spread easily between people and from infected animals. It can spread through close contact such as touching, kissing or sex, as well as through contaminated materials like sheets, clothing and needles, according to the World Health Organization. Symptoms include a fever, a painful rash, headache, muscle and back pain, low energy and enlarged lymph nodes.

For decades, the disease had largely been found in Central and West Africa, but in the 2022 outbreak, cases also began spreading in Europe and North America.

Case numbers in the US remain stable and are nowhere near as high as in 2022, when WHO declared the outbreak in North America and Europe a Public Health Emergency of International Concern. But there were about 59 new cases a week reported in the US as of the end of April, according to a report published in May, which Tuttle co-authored. By comparison, at the height of the outbreak in 2022, there were about 3,000 new cases reported per week in the US.

Another report published by the CDC Thursday looked at the kinds of patients who were seeking care at their local emergency room for mpox between June and December of last year. Of the 196 patients with rashes that doctors suspected could be mpox, three actually were infected. All three were gay or bisexual men who who engaged in sex with one or more partners that they initially met through dating apps. None had been vaccinated.

Other studies have shown that the vaccine, which is now commercially available, can help keep people safe. A recent report confirmed that two doses of the Jynneos vaccine made by Bavarian Nordic are highly effective in preventing many mpox cases. If someone who was vaccinated did get sick, the vaccine can reduce the severity of symptoms.

There have been scattered reports of infections among vaccinated people, including one cluster in May 2023 in Chicago, but these cases are rare, occurring in less than 1% of cases, the CDC said.

Mpox isn’t just an uncomfortable inconvenience. About 10% of people who got sick with mpox in the US in the latest outbreak were hospitalized, and five have died since October. People with compromised immune systems, particularly those with advanced HIV, have more severe infections, the CDC says.

Another reason to get the vaccine is the threat of a deadlier version of the virus known as clade I, which carries a case fatality rate of up to 10%, compared with 0.1% to 3.6% for clade II, the version currently in circulation in the US. This version of the disease, the CDC said, is also more transmissible. It hasn’t made its way to the US yet, but it is at the heart of an outbreak that the CDC is monitoring in the Democratic Republic of Congo. Tuttle said the Jynneos vaccine should protect against clade I as well as clade II.

“The measures that we have right now, both the vaccine and any of the antivirals, are expected to work on both clade I and clade II of the virus, should it come here,” Tuttle said.

Brian Hujdich, executive director of the National Coalition for LGBT Health, said his organization and others will continue to work hard to encourage mpox vaccination.

“With all the Pride events over the summer and just being summertime, there’s going to be more interaction. And we’ve seen already that there has been an increase in Virginia and in New York City and in some other locations,” he added. “So it might not be in numbers that get a lot of attention, but even a small increase can be a preamble to an outbreak.”

The CDC is working with the HHS Office of the Assistant Secretary of Health, local organizations and community health partners on what it calls the Summer of Pride initiative, which includes a campaign to remind people that although mpox case numbers have declined significantly, the threat has not disappeared.

“I do think some people are surprised that it is still a problem,” said Adrianna Boulin, director of racial equity, social justice and community engagement at Fenway Health, an organization that advocates for and delivers equitable care focused on the LGBTQ+ community. “Last year, we had such a robust program of getting education and information out to people, and we saw mpox rates decline initially, so everyone is surprised, like ‘wow, this is still an issue.’ It’s important for everyone to know about it, because it can impact all of us.”

Boulin, who is also president of Boston Pride of the People, the group that puts on that city’s Pride parade and celebrations on June 8, said there is a health corner at the festival where a number of organizations will talk about the programs and services they offer, including information about the mpox vaccine.

Fenway had been running mpox vaccination clinics when the outbreak started, but as the number of cases declined, fewer people were showing up, so it now offers the vaccine by appointment only.

Across the country, doses have become much more readily available than early in the outbreak, when people had to stand in long lines at special clinics. Now, pharmacies and many regular medical providers have the vaccine.

In addition to the big Pride festival, Fenway Health plans to be at several other LGBTQ events, Boulin said, and at each, workers will talk about mpox.

“People are excited that they’re outside at these events and they’re motivated, they’re open, they’re listening, and so those are all recipes for really getting information out to folks that they need to help their health,” Boulin said.

Key West Pride, which is one of the first of the year and runs from from June 5 to 9, said it will also have a visible health organization presence that will offer educational materials at its Street Fair/Dance Party about mpox and the benefits of the mpox vaccine.

The local department of health also provides resources on mpox and vaccination, he said.

Hujdich said an important message that health organizations will want to emphasize is that mpox vaccines provide not only protection but real peace of mind.

“You don’t have to be worried about being in contact with people if you’ve been vaccinated,” Hujdich said, “So it gives you the freedom to enjoy and be proud during Pride.”
 
You don’t have to be worried about being in contact with people if you’ve been vaccinated,” Hujdich said, “So it gives you the freedom to enjoy and be proud during Pride.”
Despite the fact that there have been clusters of infection among those vaccinated we encourage you to just get the shot which also has risks and then go and fuck anything that moves just as nature intended!
The amount of euphemism and pussyfooting about the point in this article is a work of art.
especially as we’re going into these summer months where risk might be heightened a little bit.”

“With all the Pride events over the summer and just being summertime, there’s going to be more interaction.
SUMMER. SUMMER IS A RISK! Yes just summer, very risky is summer.
It’s an STD mode of transmission; the safest thing to do is not fuck a load of people. Can you maybe do that?
Compare and contrast with how much peoples behaviour was restricted during Covid, you couldn’t do anything. But we can’t possibly ask gay men to stop screwing hundreds of other gay men can we? the coom must flow.
 
certain members of the LGBTQ+ community are considered especially vulnerable.
I love how they don't say why these "certain members" are vulnerable or which members of the LGBTQ community are at risk. Is it that hard to be monogamous if you're gay or whatever or do you have no choice but to stick your into anything that it will fit?
 
Back
Top Bottom